Literature DB >> 2451523

Internalization and degradation of heparin binding growth factor-I by endothelial cells.

R Friesel1, T Maciag.   

Abstract

The fate of 125I-labeled heparin binding growth factor I (125I-HBGF-I) after binding to its cell surface receptor has been studied using murine lung capillary endothelial cells (LEII). Binding of 125I-HBGF-I to its receptor at 4 degrees C shows pH dependence with optimal binding at pH 6.5-7.5. The majority (approximately 80%) of 125I-HBGF-I bound to cells at 4 degrees C can be removed by washing with low pH medium, but rapidly becomes acid resistant upon shifting cells to 37 degrees C, with 50% of the 125I-HBGF-I becoming acid resistant after 20 minutes. Electrophoretic analysis of internalized 125I-HBGF-I shows that degradation begins approximately 2 hours after internalization with the appearance of two major labeled fragments of Mr 15,000 and Mr 10,000. Degradation of internalized 125I-HBGF-I is inhibited by the lysosomotropic agent chloroquine. These data suggest that cell-associated 125I-HBGF-I is rapidly internalized and directed to a lysosomal cellular compartment where it is slowly degraded.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451523     DOI: 10.1016/s0006-291x(88)80459-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Binding of tissue plasminogen activator to human aortic endothelial cells.

Authors:  M A Sanzo; S C Howard; A J Wittwer; H M Cochrane
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

2.  Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies.

Authors:  M H Foster; T Kieber-Emmons; M Ohliger; M P Madaio
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

3.  Identification of a fibroblast growth factor-binding protein in Drosophila melanogaster.

Authors:  J S Doctor; F M Hoffmann; B B Olwin
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

4.  Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.

Authors:  Carmen Behrens; Heather Y Lin; J Jack Lee; Maria Gabriela Raso; Waun Ki Hong; Ignacio I Wistuba; Reuben Lotan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

5.  Sustained Inhibition of Proliferative Response After Transient FGF Stimulation Is Mediated by Interleukin 1 Signaling.

Authors:  Ashleigh Poole; Doreen Kacer; Emily Cooper; Francesca Tarantini; Igor Prudovsky
Journal:  J Cell Physiol       Date:  2016-03       Impact factor: 6.384

6.  Transitory FGF treatment results in the long-lasting suppression of the proliferative response to repeated FGF stimulation.

Authors:  Ashleigh Poole; Nicholas Knowland; Emily Cooper; Rebecca Cole; Hongchuan Wang; Lucas Booth; Doreen Kacer; Francesca Tarantini; Robert Friesel; Igor Prudovsky
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

7.  Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints.

Authors:  H Sano; R Forough; J A Maier; J P Case; A Jackson; K Engleka; T Maciag; R L Wilder
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

8.  Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.

Authors:  W H Burgess; A M Shaheen; M Ravera; M Jaye; P J Donohue; J A Winkles
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

9.  Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2.

Authors:  P A Maher
Journal:  J Cell Biol       Date:  1996-07       Impact factor: 10.539

10.  Activation of the MAP kinase pathway by FGF-1 correlates with cell proliferation induction while activation of the Src pathway correlates with migration.

Authors:  T M LaVallee; I A Prudovsky; G A McMahon; X Hu; T Maciag
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.